Publications by authors named "Ryan Qin"

Claim this Profile
R
Recommendations for achieving interoperable and shareable medical data in the USA.
Ana Szarfman, Jonathan G Levine, Joseph M Tonning, Frank Weichold, John C Bloom, Qin Ryan

Commun Med (Lond)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle.
Amarilys Vega, Rongmei Zhang, Hui-Lee Wong, Michael Wernecke, Michael Alexander, Qin Ryan

Pharmacoepidemiol Drug Saf· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare.
Cunlin Wang, Robert Kane, Mark Levenson, Jeffrey Kelman, Michael Wernecke, Yuqin Wei, Qin Ryan

JAMA Intern Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
Cunlin Wang, David J Graham, Robert C Kane, Diqiong Xie, Michael Wernecke, Qin Ryan

JAMA· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms.
William D Figg, Manish Monga, Donna Headlee, Avni Shah, Cindy H Chau, Qin C Ryan

Cancer Chemother Pharmacol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide characterisation of gene expression in rice leaf blades at 25 °C and 30 °C.
Zhi-guo E, Lei Wang, Ryan Qin, Haihong Shen, Jianhua Zhou

ScientificWorldJournal· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predominant expression of exon 7 skipped SMN mRNAs in lung based on analysis of transcriptome sequencing datasets.
Xiaoming Yang, Haihong Shen, Xue Gao, Xuexiu Zheng, Ryan Qin

Neurol Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.
Qin Ryan, Amna Ibrahim, Martin H Cohen, John Johnson, Chia-wen Ko

Oncologist· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.
Shivaani Kummar, Martin Gutierrez, Erin R Gardner, Erin Donovan, Kyunghwa Hwang, Qin C Ryan

Clin Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer.
Milin R Acharya, Judith E Karp, Edward A Sausville, Kyunghwa Hwang, Qin Ryan

Invest New Drugs· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibitor pharmacodynamic analysis by multiparameter flow cytometry.
Eun Joo Chung, Sunmin Lee, Edward A Sausville, Qin Ryan, Judith E Karp

Ann Clin Lab Sci· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma.
Qin C Ryan, Donna Headlee, Milin Acharya, Alex Sparreboom, Jane B Trepel

J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.
John D Nguyen, Jorge A Carrasquillo, Richard F Little, Qin C Ryan, Wyndham Wilson

Clin Nucl Med· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis